Hypertension program Categories

Our programs are provided in two forms, a long-term and a periodic (short-term) digital therapeutics programs. The difference between the two is in the period of service and the components of the programs.

Short-term BP monitoring

This is a 2 - 6 weeks remote blood pressure monitoring (RBPM) program, with a purpose of diagnosing hypertension in a patient and confirming therapeutic efficacy.

Long-term BP Monitoring

This a 12-month high blood pressure (hypertension) digital therapeutics program. It is forindividuals diagnosed and on treatment for hypertension.

Short-Term monitoring of blood pressure

This service is ussually provided to primary care health professionals. The purpose for the program is two-fold;

  1. Diagnosing high blood pressure - The patient is provided with our innovative blood pressure monitor and trained on its use. For a period of 2 weeks the patient will self-measure their BP at home, and our team will monitor and peform BP analytics on the biodata. This exercise with exclude those patients with "white coat phenomenon" and diagnose those with masked hypertension.

  2. Therapeutic monitoring - This solution is available to ensure the efficacy of prescribed anti-hypertensive treatment in both initial treatment and ongoing treatment. It basically confirms control of blood pressure.

Hypertension digital therapeutics

Every subscribing individual is provided with training and education about hypertension and the use of digital health technology. We provide the subscriber with a digital blood pressure (BP) monitor with Bluetooth technology, which empowers the user to digitally record their self-measured BP readings/ data onto our digital health platform via an App on their mobile device. 

Our healthcare professional team monitors BP changes, trends and analytics so as to provide data informed collaborative care. In partnership with the subscriber's treating clinician, our team is able to deliver active hypertension disease risk management to the patient-subscriber, thereby preventing disease complications associated with uncontrolled hypertension.